Literature DB >> 26077354

Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH.

Blake B Anderson1, Joseph J Pariser, Brian T Helfand.   

Abstract

Transurethral resection of the prostate (TURP) and photoselective vaporization of the prostate (PVP) are currently the two most commonly performed procedures for the treatment of benign prostatic hyperplasia (BPH). While each procedure has been shown to be efficacious, TURP or PVP may be preferred in certain clinical scenarios. A number of factors may influence the choice of which patients undergo PVP or TURP. This decision may take into account patient characteristics, such as age, co-morbidities, predominance of irritative symptoms, and/or ongoing anticoagulation. Additionally, balancing desired outcomes with possible risks is critical. Considerations should include possible effects on sexual function, rates of reoperation, cost, and need for tissue specimen in those at risk for prostate cancer. The primary objective of this article is to summarize the comparative research of PVP and TURP and the implications on differences between patients who undergo either procedure.

Entities:  

Mesh:

Year:  2015        PMID: 26077354     DOI: 10.1007/s11934-015-0525-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  52 in total

1.  180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  Eur Urol       Date:  2013-11-11       Impact factor: 20.096

2.  Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia.

Authors:  Seth A Strope; Liu Yang; Kenneth G Nepple; Gerald L Andriole; Pamela L Owens
Journal:  J Urol       Date:  2012-02-15       Impact factor: 7.450

3.  Long term prostate-specific antigen trends following subcapsular prostatectomy.

Authors:  Adam P Klausner; Blake B Anderson; Paul G Espy; Vidal M Despradel; B Mayer Grob
Journal:  Can J Urol       Date:  2010-12       Impact factor: 1.344

4.  Clinically significant prostate cancer is rarely missed by ablative procedures of the prostate in men with prostate specific antigen less than 4 ng/ml.

Authors:  Joshua J Meeks; Alexandra C Maschino; Kevin T McVary; Jaspreet S Sandhu
Journal:  J Urol       Date:  2012-11-16       Impact factor: 7.450

5.  [Evaluation of sexual activity after prostatic surgery for benign prostatic hyperplasia assessed by pre-operative and post-operative questionnaire].

Authors:  G Franco; C De Nunzio; G Federico; C Laurenti
Journal:  Minerva Urol Nefrol       Date:  2005-12       Impact factor: 3.720

Review 6.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

7.  Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms.

Authors:  Cosimo De Nunzio; Roberto Miano; Alberto Trucchi; Lucio Miano; Giorgio Franco; Stefano Squillacciotti; Andrea Tubaro
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

8.  A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  J Urol       Date:  2014-09-16       Impact factor: 7.450

9.  A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.

Authors:  Jennifer A Whitty; Paul Crosland; Kaye Hewson; Rajan Narula; Timothy R Nathan; Peter A Campbell; Andrew Keller; Paul A Scuffham
Journal:  BJU Int       Date:  2013-04-10       Impact factor: 5.588

10.  The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen.

Authors:  Hee Ju Cho; Soon Cheol Shin; Jeong Man Cho; Jung Yoon Kang; Tag Keun Yoo
Journal:  Prostate Int       Date:  2014-12-30
View more
  2 in total

1.  Comparison of thermal injury depth of the prostate between plasma kinetic electrode, holmium laser, green light laser and Nd:YAG laser.

Authors:  Meng Gu; Yanbo Chen; Ming Zhan; Chong Liu; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Int Urol Nephrol       Date:  2021-01-22       Impact factor: 2.370

2.  Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml.

Authors:  Jie Sun; An Shi; Zhen Tong; Chenfei Chi
Journal:  Lasers Med Sci       Date:  2018-04-28       Impact factor: 3.161

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.